JAG1 and cancer: More than half of the Jag1/2 KO mice developed carcinoma in situ or invasive SCC, whereas the majority of the WT or the p63CreERT2/+ mice only displayed epithelial hyperplasia or dysplasia (Fig. 7e and Supplementary Fig. 4b-d).